| 2001 |
Set1 (yeast ortholog of SETD1A) is the sole histone H3 lysine 4 methyltransferase in S. cerevisiae; deletion of SET1 abolishes all H3K4 methylation in vivo, and this can be rescued by re-expression of SET1. |
Genetic deletion, in vivo histone methylation assay with methyl-specific antiserum, complementation rescue |
Genes & development |
High |
11742990 11751634
|
| 2001 |
Set1 exists as an eight-subunit complex (Set1C/COMPASS), which includes an Ash2/Bre2 homologue; complex integrity requires Set1, and loss of Set1 disrupts the complex. |
Co-immunoprecipitation, mass spectrometry, biochemical fractionation |
The EMBO journal |
High |
11742990
|
| 2003 |
Set1 is recruited to the 5' portion of active mRNA coding regions by the Pol II elongation machinery; Set1 physically interacts with the Ser5-phosphorylated (but not Ser2-phosphorylated) form of the Pol II CTD, and its recruitment depends on the TFIIH-associated CTD kinase and on Rtf1/Paf1 components of the Paf1 complex. |
Chromatin immunoprecipitation (ChIP), co-immunoprecipitation, genetic epistasis with CTD kinase and Paf1 complex mutants |
Molecular cell |
High |
12667453
|
| 2003 |
Human Set1/Ash2 histone methyltransferase complex (containing SETD1A) methylates histone H3 at Lys4 but not if the neighboring K9 residue is already methylated; HCF-1 tethers this Set1/Ash2 HMT complex together with the Sin3 HDAC complex, and the transcriptional activator VP16 selectively binds HCF-1 associated with Set1/Ash2 in the absence of Sin3. |
In vitro histone methyltransferase assay, co-immunoprecipitation, domain mapping |
Genes & development |
High |
12670868
|
| 2005 |
Human CFP1 (CXXC finger protein 1) is a component of the mammalian SETD1A/Set1 complex; the complex produces mono-, di-, and trimethylated H3K4 in vitro; CFP1 and SETD1A co-localize to nuclear speckles associated with euchromatin; cells lacking CFP1 show elevated H3K4 methylation, indicating CFP1 restricts SETD1A activity. |
Co-immunoprecipitation, mass spectrometry, in vitro methyltransferase assay, confocal microscopy, genetic knockout of CFP1 |
The Journal of biological chemistry |
High |
16253997
|
| 2005 |
H2B ubiquitylation at K123 is dispensable for monomethylation of H3K4 by Set1 but is required for the transition from monomethylation to di- and trimethylation (processive methylation); Dot1 binding to chromatin is normal without H2Bub, suggesting ubiquitylation regulates processivity rather than recruitment. |
Chromatin immunoprecipitation, mass spectrometry, genetic mutation of H2B K123 |
Molecular cell |
High |
16039595
|
| 2005 |
The N-terminal region of Set1 is required for global H3K4 trimethylation; Set1 trimethyl-defective N-terminal mutants are defective in telomere, rDNA, HML, and HMR silencing, while mono- and/or dimethylation by Set1 is sufficient for cell growth. |
Yeast genetics, site-directed mutagenesis, chromatin immunoprecipitation, silencing assays |
The Journal of biological chemistry |
Medium |
15964832
|
| 2005 |
Set1 methyltransferase is required for methylation of conserved lysines in the kinetochore protein Dam1; Dam1 methylation by Set1 inhibits Ipl1 Aurora kinase-mediated phosphorylation of flanking serines, with SET1 deletion suppressing chromosome loss in ipl1-2 cells; this function is independent of Set1's role in H3K4 methylation and transcription. |
Genetic epistasis (suppressor analysis of ipl1-2), biochemical methylation assay of Dam1, genetic double-mutant analysis |
Cell |
High |
16143104
|
| 2005 |
The RNA recognition motif 1 (RRM1) of Set1, when combined with a newly identified RRM2, specifically binds RNA in vitro; RRM1 mutation destabilizes Set1 and alters the ratio of H3K4 di- to trimethylation at active genes, reducing trimethylation while increasing dimethylation at 5'-coding regions. |
Crystal structure of RRM1, RNA-binding assay in vitro, in vivo H3K4 methylation analysis by ChIP, site-directed mutagenesis |
The EMBO journal |
High |
15775977
|
| 2006 |
Within the Set1 complex, Swd1 and Swd3 are required for complex integrity and Set1 stability; the Bre2-Sdc1 heterodimer is required for H3K4 trimethylation at the 5' end of active genes; Set1C associates with both Ser5- and Ser2-phosphorylated forms of Pol II, indicating persistent association throughout transcription. |
Co-immunoprecipitation, genetic deletion of individual subunits, western blot for Set1 levels, ChIP |
The Journal of biological chemistry |
High |
16921172
|
| 2007 |
The Wdr82 component of the human SETD1A complex interacts with the RNA recognition motif of SETD1A and binds to the Ser5-phosphorylated CTD of RNA Pol II (but not unphosphorylated or Ser2-phosphorylated CTD); siRNA depletion of Wdr82 decreases SETD1A expression and its occupancy at transcription start sites and reduces H3K4me3 at those sites, without altering Pol II occupancy or target gene expression. |
Co-immunoprecipitation, peptide binding assays, chromatin immunoprecipitation, siRNA knockdown |
Molecular and cellular biology |
High |
17998332
|
| 2007 |
HCF-1 recruits SETD1A (Set1) and MLL1 histone methyltransferases to herpesvirus immediate early promoters, leading to H3K4me3 and transcriptional activation; HCF-1 is required for this chromatin modification step but not for assembly of the basal RNAPII complex. |
ChIP at viral promoters, epistasis with HCF-1, promoter reporter assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
17578910
|
| 2008 |
Wdr82 is a specific component of the human Set1A/B complexes but not MLL1-4 complexes; siRNA knockdown of Wdr82 reduces H3K4 trimethylation levels in vivo; in vitro, the Set1 complex is a more robust H3K4 trimethylase than MLL complexes. |
Affinity purification/mass spectrometry, RNAi knockdown, in vitro histone methyltransferase assay |
Molecular and cellular biology |
High |
18838538
|
| 2009 |
Tyr1052 (the Phe/Tyr switch) in the catalytic domain of Set1 is essential for H3K4 trimethylation by COMPASS; mutation Y1052F suppresses the trimethylation defect caused by loss of Cps40/Spp1, but does not suppress defects from loss of H2B monoubiquitination, indicating Tyr1052 and Cps40 function together downstream of and independently of H2Bub. |
Homology modeling, site-directed mutagenesis, in vivo H3K4 methylation analysis, ChIP |
Molecular and cellular biology |
Medium |
19398585
|
| 2009 |
H3K4 dimethylation by Set1 recruits the Set3 histone deacetylase complex via the Set3 PHD finger to 5' transcribed regions, where Hos2 and Hst1 deacetylate histones; this reduces histone acetylation near 5' ends of genes and positively affects transcription elongation. |
Genetic epistasis, ChIP, PHD finger binding assay, growth assays on mycophenolic acid |
Cell |
High |
19379692
|
| 2009 |
CFP1 restricts the SETD1A complex to euchromatin; in CFP1-null ES cells, SETD1A and H3K4me3 mislocalize to heterochromatin; both the DNA-binding activity of CFP1 and its interaction with the SETD1A complex are required for proper SETD1A genomic targeting. |
Confocal microscopy, genetic knockout (CXXC1-/-), structure-function analysis of CFP1 point mutations and truncations |
The FEBS journal |
Medium |
19951360
|
| 2012 |
WDR5 binds the Win (WDR5-interacting) motifs of MLL2-4, SET1A, and SET1B; crystal structures of WDR5-Win complexes show binding is achieved by plasticity of WDR5's peptidyl-arginine-binding cleft; WDR5 is important for optimal stimulation of SET1A methyltransferase activity by the RbBP5-ASH2L heterodimer. |
Crystal structure determination, biochemical binding assays, in vitro methyltransferase assay |
Nucleic acids research |
High |
22266653
|
| 2013 |
TET2 and TET3 directly interact with OGT; TET2/3-OGT co-localize on chromatin at H3K4me3-enriched active promoters; reduction of TET2/3 or OGT activity decreases H3K4me3 and transcription; HCF1, a SET1/COMPASS component, is a specific GlcNAcylation target of TET2/3-OGT, and HCF1 modification is important for COMPASS integrity; TET proteins and OGT promote chromatin binding of SETD1A. |
Co-immunoprecipitation, ChIP, OGT activity assays, knockdown of TET2/3 and OGT, mass spectrometry identification of HCF1 GlcNAcylation |
The EMBO journal |
High |
23353889
|
| 2013 |
The n-SET domain of Set1 (but not Swd2) is essential for H2Bub-dependent H3K4 methylation on reconstituted chromatin templates; Spp1 (CFP1 homolog) is conditionally involved in this crosstalk; this mechanism is conserved in the human Set1 complex. |
In vitro histone methyltransferase assay with reconstituted yeast Set1 complex and fully ubiquitylated H2B chromatin template, n-SET domain mutagenesis, genetic analyses |
Molecular cell |
High |
23453808
|
| 2013 |
In vitro studies with recombinant chromatin and purified human SET1 complex (SET1C) show robust H3K4me3 that is dependent on p53/p300-mediated H3 acetylation; SET1C directly interacts with p53 and p300; DNA-damage induces p53-SET1C interaction in cells with enrichment of SET1C and H3K4me3 at the p21/WAF1 promoter; H3K4me3 and transcription codepend on both SET1C and p300. |
In vitro transcription/methylation assay with recombinant chromatin, Co-IP, ChIP, cell-based assays with DNA damage |
Cell |
High |
23870121
|
| 2013 |
Quantitative mass spectrometry revealed Bod1 protein as a discriminator between SET1B and SET1A complexes, distinguishing their subunit composition; DPY30 is a genuine subunit of both SET1/MLL complexes and the NURF chromatin remodeling complex. |
Label-free quantitative mass spectrometry, affinity purification |
Molecular and cellular biology |
Medium |
23508102
|
| 2014 |
Mouse Setd1a is required for gastrulation; Setd1a knockout embryos implant but fail to progress past the epiblast stage; deletion of Setd1a in ES cells causes rapid loss of bulk H3K4 methylation, pluripotency gene expression, and proliferation with G1 arrest; Setd1b overexpression cannot rescue the proliferation defects caused by Setd1a loss. |
Conditional gene knockout in mice, ES cell deletion, western blot for H3K4 methylation, flow cytometry for cell cycle |
Development |
High |
24550110
|
| 2015 |
SETD1A suppresses BTG2 expression through induction of BTG2-targeting miRNAs, not through direct chromatin repression of BTG2; this indirect miRNA-dependent mechanism regulates cell cycle progression in vitro and tumorigenesis in mouse xenograft models. |
shRNA screen of 43 histone KMTs, miRNA profiling, cell cycle assays, xenograft tumor models |
Nature communications |
Medium |
26394836
|
| 2015 |
Biochemical reconstitution of each human SET1 family core complex shows that in the absence of WRAD all SET domains catalyze at least weak H3K4 monomethylation; in the presence of WRAD, all SET1 family members show stimulated monomethyltransferase activity but differ in di- and trimethylation activities correlated with evolutionary lineage; phylogenetic scanning mutagenesis identified a cluster of residues that confer WRAD-dependent gain-of-function dimethylation activity. |
Biochemical reconstitution of core complexes, in vitro methyltransferase assays, phylogenetic mutagenesis |
The Journal of biological chemistry |
High |
25561738
|
| 2015 |
SET1 (SETD1A) mediates H3K4me3 accumulation at the endothelin-1 (EDN1) promoter in endothelial cells upon angiotensin II stimulation; SET1 is recruited to the EDN1 promoter by AP-1 (c-Jun/c-Fos) and synergizes with AP-1 to activate transcription; endothelial-specific deletion of SET1 in mice attenuates Ang II-induced cardiac hypertrophy and fibrosis. |
ChIP, Co-IP, siRNA knockdown, conditional knockout mice, cardiomyocyte hypertrophy assay |
Arteriosclerosis, thrombosis, and vascular biology |
Medium |
25814673
|
| 2016 |
Mutation of the Win motif-WDR5 interface severely disrupts assembly and activity of MLL1 and SETd1A complexes but only modestly disrupts MLL2/4 and SETd1B complexes; a peptidomimetic targeting the Win motif-WDR5 interaction selectively inhibits MLL1 and SETd1A core complex activity within the SET1 family. |
Biochemical reconstitution, in vitro methyltransferase assay, Win motif mutagenesis, peptide inhibitor design and enzymatic assay |
The Journal of biological chemistry |
High |
27563068
|
| 2016 |
Among SET1/MLL family H3K4 methyltransferases, Set1a specifically interacts with Oct4; this interaction is independent of Wdr5; Set1a is recruited to and required for H3K4 methylation at Oct4 target gene promoters; Set1a is required for ES cell maintenance, iPSC generation, and generation of Oct4-positive inner cell mass. |
Co-immunoprecipitation, ChIP, ChIP-seq, gene knockout, gene expression profiling |
Stem cells |
High |
26785054
|
| 2017 |
The vertebrate SET1 complex is targeted to actively transcribed gene promoters through CFP1, which engages in multivalent chromatin reading involving recognition of non-methylated CpG DNA and H3K4me3; CFP1 defines SET1 complex occupancy on chromatin and its multivalent interactions are required for the SET1 complex to place H3K4me3; loss of CFP1 perturbs gene expression. |
Live-cell imaging, functional genomics (ChIP-seq), CFP1 point mutant analysis |
Cell reports |
High |
28877467
|
| 2017 |
Nup98 binds predominantly to transcription start sites in hematopoietic cells and recruits the Wdr82-Set1A/COMPASS complex, which is required for H3K4me3 deposition; depletion of Nup98 or Wdr82 abolishes Set1A recruitment to chromatin and abrogates H3K4me3 at adjacent promoters; AML-associated Nup98 fusion protein causes mislocalization of H3K4me3. |
ChIP-seq, siRNA knockdown, co-immunoprecipitation, protein localization |
Genes & development |
High |
29269482
|
| 2017 |
Set1 complex directly binds RNA in vitro through the double RRM and N-SET domain of Set1 and through its subunit Spp1; RNA binding (CRAC assay) shows Set1 binds nascent transcripts near transcription start sites; RNA binding is important for appropriate topology of Set1C distribution along transcription units and correlates with efficient H3K4me3 deposition; Set1 also binds non-nascent RNAs including Ty1 retrotransposons and its own mRNA. |
In vitro RNA binding assay, UV RNA crosslinking (CRAC), ChIP-seq, parallel analysis of RNAPII binding |
Cell discovery |
Medium |
29071121
|
| 2018 |
SET1A mediates mono-methylation of YAP at K342, which disrupts YAP's binding to CRM1 and blocks its nuclear export, thereby sequestering active YAP in the nucleus; YAP K342 methylation knockin mice are more susceptible to colorectal tumorigenesis. |
In vitro methylation assay, co-immunoprecipitation, nuclear export assay, knockin mouse model, mutagenesis |
Cancer cell |
High |
30008322
|
| 2018 |
SETD1A has an essential non-catalytic function through a newly identified 'FLOS' domain that acts as a cyclin-K-binding site; FLOS disruption suppresses DNA damage response genes and induces p53-dependent apoptosis in AML cells; the FLOS domain is required for chromosomal recruitment of cyclin K and DNA-repair-associated gene expression in S phase; the enzymatic SET domain is not necessary for AML cell survival. |
CRISPR-Cas9 domain screening, mutagenesis studies, co-immunoprecipitation (SETD1A-cyclin K), ChIP, apoptosis assays |
Cell |
High |
29474905
|
| 2018 |
SETD1A catalyzes H3K4 methylation at stalled replication forks, which enhances FANCD2-dependent histone chaperone activity; depletion of SETD1A leads to DNA2-dependent resection of damaged replication forks; suppressing H3K4 methylation or expression of a chaperone-defective FANCD2 mutant leads to loss of RAD51 nucleofilament stability and nucleolytic fork degradation. |
Depletion/siRNA of SETD1A, fork degradation assays, H3K4 methylation ChIP at replication forks, FANCD2 chaperone mutant analysis, RAD51 foci |
Molecular cell |
High |
29937342
|
| 2018 |
Uhrf1 forms a complex with Setd1a/COMPASS to maintain bivalent H3K4me3/H3K27me3 histone marks in ES cells, particularly those associated with neuroectoderm and mesoderm specification. |
Co-immunoprecipitation, ChIP-seq, knockdown of Uhrf1 |
Nature communications |
Medium |
29968706
|
| 2018 |
SETD1A is recruited to the THBD (thrombomodulin) promoter by the transcription factor KLF4 in response to retinoic acid; SETD1A also mediates H3K4me3-dependent upregulation of KLF4 expression via retinoic acid receptor; SETD1A knockdown reduces H3K4me3 at the THBD promoter and blocks retinoic acid-induced thrombomodulin transcription. |
ChIP, Co-IP, siRNA knockdown, reporter assay |
Biochimica et biophysica acta. Gene regulatory mechanisms |
Medium |
29940355
|
| 2018 |
SETD1A protects hematopoietic stem cells (HSCs) from activation-induced functional decline; conditional deletion of Setd1a in adult LT-HSCs is compatible with steady-state hematopoiesis but causes loss of transcriptional cellular identity, proliferative capacity, and stem cell function under replicative stress or after transplantation; SETD1A regulates expression of DNA damage recognition and repair pathways in HSCs. |
Conditional gene knockout (Setd1a-cKO in LT-HSCs), transplantation assays, RNA-seq, ChIP |
Blood |
High |
29348130
|
| 2019 |
Setd1a heterozygous loss-of-function mice exhibit axonal branching defects, altered cortical synaptic dynamics, and working memory deficits; Setd1a binds both promoters and enhancers with striking overlap with Mef2 on enhancers; LSD1 is identified as a major counteracting demethylase for Setd1a; pharmacological inhibition of LSD1 rescues behavioral and morphological deficits in Setd1a-deficient mice. |
Heterozygous mouse model (Setd1a+/-), ChIP-seq for Setd1a binding, morphological analysis of axons, behavioral testing, LSD1 inhibitor treatment |
Neuron |
High |
31606247
|
| 2020 |
The Set1 N-terminal region and COMPASS subunit Swd2 interact with each other and are both needed for efficient Pol II CTD binding; a single point mutation in Swd2 that affects its interaction with Set1 impairs COMPASS recruitment to chromatin and H3K4 methylation; H2B ubiquitylation is still required for efficient H3K4 methylation even when Set1/COMPASS is recruited via an alternative CTD interaction domain (Nrd1 CID), indicating H2Bub acts after initial COMPASS recruitment. |
Co-immunoprecipitation, CTD pulldown assays, point mutagenesis of Swd2, ChIP, domain swap experiments |
Nature communications |
High |
32358498
|
| 2020 |
SETD1A interacts with HIF1α and co-occupies the promoters of glycolytic genes (HK2, PFK2); SETD1A methylates H3K4 at these promoters to strengthen HIF1α transactivation; knockdown of SETD1A reduces H3K4 methylation at HK2 and PFK2 promoters, reduces HIF1α recruitment, and decreases glycolytic gene expression and glycolysis. |
Co-immunoprecipitation (SETD1A-HIF1α), ChIP (SETD1A and H3K4me3), siRNA knockdown, metabolic assays |
Molecular oncology |
Medium |
32291851
|
| 2020 |
Setd1a haploinsufficiency in mice causes highly variable transcriptional adaptations across different cell types in prefrontal cortex and striatum; Foxp2+ neurons show the most prominent gene expression changes that correlate with changes in H3K4me3; dysregulated genes involve neuron morphogenesis and synaptic function. |
Single-cell RNA sequencing in Setd1a+/- mice, H3K4me3 ChIP-seq, behavioral assays |
Science advances |
Medium |
35245111
|
| 2020 |
Setd1a knockdown in layer 2/3 pyramidal neurons of the medial prefrontal cortex specifically recapitulates impaired sociality; postsynaptic Setd1a is essential for excitatory synaptic transmission as demonstrated by optogenetics-assisted selective stimulation of presynaptic neurons combined with Setd1a RNAi knockdown. |
Conditional Setd1a knockdown by RNAi in specific neurons, optogenetics, electrophysiology, behavioral assays |
Cell reports |
Medium |
32937141
|
| 2021 |
SETD1A interacts with and stabilizes β-catenin (through a SET-domain-independent mechanism) to positively regulate the Wnt/β-catenin pathway; SETD1A also binds to the promoters of NEAT1 and EZH2 to activate transcription via H3K4me3 enrichment, contributing to cancer stem cell properties; a positive feedback loop exists where SETD1A is a direct target of the Wnt/β-catenin pathway. |
Co-immunoprecipitation (SETD1A-β-catenin), ChIP, luciferase reporter, SET domain deletion mutant analysis |
Journal of experimental & clinical cancer research |
Medium |
34645486
|
| 2022 |
H3K4 methylation by SETD1A-BOD1L facilitates recruitment of RIF1 to DSBs; RIF1 directly binds methylated H3K4; compromising SETD1A or BOD1L expression impairs RIF1 localization to DSBs, leads to uncontrolled DNA end resection, impairs telomere end-joining and class switch recombination; patient cells with SETD1A loss-of-function mutations show RIF1 localization defects; loss of SETD1A-dependent RIF1 recruitment in BRCA1-deficient cells restores homologous recombination. |
Co-immunoprecipitation, RIF1 foci assays, DNA end-joining assays (telomere FISH, class switch recombination), patient cell lines with SETD1A LoF, BRCA1-deficient cell epistasis, direct binding assay (RIF1 to H3K4me peptides) |
Molecular cell |
High |
35439434
|
| 2022 |
SETD1A haploinsufficiency in human iPSC-derived excitatory/inhibitory neuronal networks results in increased dendritic complexity and increased network bursting activity; perturbations in glutamatergic synaptic function genes and hyperactive cAMP/PKA pathway were identified; pharmacological targeting of the cAMP pathway rescues the network deficits. |
CRISPR-Cas9 SETD1A+/- iPSC-derived neurons, multi-electrode array, transcriptomics, cAMP pathway pharmacological rescue |
Cell reports |
Medium |
35508131
|